Purpose of Study:
To evaluate a potential treatment for MAC lung infection and its impact on symptoms including respiratory discomfort and fatigue.
Study Dates:
October 1, 2020 - May 31, 2022
Type of Study:
Pre-Market
Study Design:
Controlled Design
Study Location:
Nationwide
Funding Source:
Insmed Incorporated
Sponsors:
Insmed Incorporated
What is the identifier for this study on ClinicalTrials.gov?
ARISE: https://clinicaltrials.gov/ct2/show/NCT04677543
ENCORE: https://www.clinicaltrials.gov/ct2/show/NCT04677569
